The Australian government has filed a lawsuit against US industrial giant 3M, accusing it of knowingly marketing firefighting foams containing dangerous ‘forever chemicals’ that have contaminated groundwater and soil across the country. This is a classic case of corporate cost-benefit analysis gone awry. For decades, 3M sold its aqueous film-forming foam (AFFF) to the Australian defence force and airports without adequate warnings about per- and polyfluoroalkyl substances (PFAS), which do not break down in the environment. The result? A toxic legacy that will cost billions to clean up.
Let’s talk about the numbers. The Australian Department of Defence has already allocated over $400 million for PFAS management and remediation. But that is merely a down payment. Independent estimates suggest the total liability could run into the tens of billions. 3M, with a market capitalisation of roughly $120 billion, has set aside only around $1 billion for global PFAS litigation. That is an accounting mismatch of epic proportions.
This lawsuit is not just about water contamination; it is about capital flight and liability transfer. 3M’s shareholders have enjoyed decades of profits from AFFF sales, while the Australian taxpayer now picks up the tab for healthcare monitoring and property devaluation. The same pattern played out in the US, where 3M recently settled a $10.3 billion claim with public water suppliers. Australia is now playing catch-up.
The ‘forever chemicals’ in question have a half-life measured in years, not days. They accumulate in the human body and have been linked to cancer, liver damage, and immune system disruption. The real cost cannot be captured by any balance sheet. It is a contingent liability that keeps compounding.
From a fiscal responsibility standpoint, the Australian government is right to seek strict liability. If 3M knew the risks and continued selling, the burden falls on the manufacturer. The company’s defence will likely hinge on compliance with outdated safety standards. But the market has already priced in further litigation: 3M′s stock has underperformed the S&P 500 by 15% over the past year.
Investors should note that this is a global trend. The European Union has proposed banning PFAS entirely, and the US Environmental Protection Agency is tightening drinking water limits. For 3M, the ‘forever chemicals’ are becoming a forever drag on earnings. The bottom line: when a product’s lifespan exceeds human lifetime, the liability does too. Australia’s lawsuit is another chapter in the long unwind of chemical ‘innovation’ without accountability.
